Division of Biomedical Research & Development Iwate Medical University Institute for Biomedical Sciences


  • 2023.09.02

    Nishizuka gave an introductory talk at Thermo Fisher Scientific Genetic Solutions Tour Taiwan 2023 for the OTS-Assay.
  • 2023.07.18

    A gastric cancer cell line, IWT-1 is now available through RIKEN Cell Bank. Link
  • 2023.07.13

    List as an European Liquid Biopsy Society Academic Partner. Link
  • 2023.06.19

    Nishizuka interview is released in Shukan(weekly) Post.
  • 2023.04.23

    Nishizuka presented in the evant by the "Esophageal Cancer Suvivor's Share Rings" foundation. Link1 Link2 Link3

Alteration of
an Opt-Out Choice

Last Updated : 2023.09.05


Our patient opt-out policy permits participants to choose whether they want to use their personal information and specimens provided for our medical research. According to the policy of the Japanese Government, patients or people acting as their proxies have the right to alter the opt-out choice they made when giving informed consent for the medical research. We are currently announcing the above protocols for the opt-out opportunities. Please note, however, that we may not be able to identify individuals once their personal information and specimens provided for our medical research have been anonymously processed.